Гормонотерапия в акушерстве и гинекологии. Иллюзии и реальность

da Fonseca E. B., et al. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am. J. Obstet. Gynecol., 2003; 188:419–424.

Dahmoun M., et al. Apoptosis, proliferation, and sex hormone receptors in superficial parts of human endometrium at the end of the secretory phase. J. Clin. Endocrinol. Metab., 1999; 84:1737–1743.

Dal Prato L., Borini A. Use of antagonists in ovarian stimulation protocols. Reprod. Biomed. Online, 2005; 10:330–338.

Dalton K. Ante-natal Progesterone and Intelligence. BJP, 1968; 114:1377–1382.

Dalton K. Prenatal progesterone and educational attainments. BJP, 1976; 129:438–442.

Daneshmand S., et al. Very early hCG dynamics predict pregnancy loss at up to 10 weeks gestation. Fertil. Steril., 2007; 88:S159.

Danilenko K., Sergeeva O., Verevkin E. Menstrual cycles are influenced by sunshine. Gynecol. Endocrinol., 2011; 27 (9):711–716.

Das R. M., Martin L. Progesterone inhibition of mouse uterine epithelial proliferation. J. Endocrinol. 1973; 59:205–206.

Davies J., Kadir R. A. Endometrial haemostasis and menstruation. Rev. Endocr. Metab. Disord., 2012; 13:289–299.

Davison S. Salivary testing opens a Pandora’s box of issues surrounding accurate measurement of testosterone in women. Menopause, 2009; 16:630–631.

Dawood M. Y. Corpus luteal insufficiency. Curr. Opin. Obstet. Gynecol., 1994; 6:121–127.

Dawson R. F. Diosgenin Production in North America: A Brief History. American Society for Horticultural Science. HortTechnology, 1991; 1:22–27.

Daya S., Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst. Rev., 2004; 3:CD004830.

Daya S. Efficacy of progesterone support for pregnancy in women with recurrent miscarriage. A meta-analysis of controlled trials. Br. J. Obstet. Gynecol., 1989; 96:257–260.

Daya S. Evaluation and management of recurrent spontaneous abortion. Curr. Opin. Obstet. Gynecol., 1993; 8:188–192.

Daya S. Human chorionic gonadotropin increase in normal early pregnancy. Am. J. Obstet. Gynecol., 1987; 156:286–290.

Daya S. Immunotherapy for unexplained recurrent spontaneous abortion. Infertil. Reprod. Med. Clin. North. Am., 1997; 8:65–77.

Daya S. Issues in the etiology of recurrent spontaneous abortion. Curr. Opin. Obstet. Gynecol., 1994; 6:153–159.

De Geyter, et al. Progesterone serum level during the follicular phase of the menstrual cycle originate from crosstalk between the ovaries and adrenal cortex. Human Reproduction, 2002; 17:4:933–939.

De Lignieres B., et al. Indluence of route administration on progesterone metacolism. Maturitas, 1995; 21:251–257.

de Lignieres B. Oral micronized progesterone. Clin. Ther., 1999; 21:41–60; discussion 1–2.

De Souza A., et al. Genital anomalies with maternal exposure to progesterone in mice. American Urological Society Annual Meeting, San Francisco, May 8–13, 2004.

De Vivo I., et al. A functional polymorphism in the promoter of the progesterone receptor gene associated with endometrial cancer risk. Proc. Natl. Acad. Sci. USA, 2002; 99:12263–12268.

Dean H. J., Winter J. S. The effect of five synthetic progestational compounds on 5-alpha-reductase activity in genital skin fibroblast monolayers. Steroids, 1984; 43:13–24.

DeFranco E. A., et al. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial. Ultrasound Obstet. Gynecol., 2007;30:697–705.

Dennerstein L., et al. Mood and the menopausal transition. J. Nerv. Ment. Dis.,1999;187:685–691.

Dennis C. L., Ross L. E., Herxheimer A. Oestrogens and progestins for preventing and treating postpartum depression. Cochrane Database Syst. Rev., 2008; 4:CD001690.

Derry P. S., Derry G. N. Menstruation, Perimenopause, and Chaos Theory. Perspectives in Biology and Medicine, 2012; 55 (1):26–42.

Desreux J., et al. Progesterone receptor activation: an alternative to SERMs in breast cancer. Eur. J. Cancer, 2000; 36 (sup. 4):90–91.

Dey S. K., et al. Molecular cues to implantation. Endocrine Reviews, 2004; 25:341–373.

Di Carlo C., et al. Use of leuprolide acetate plus tibolone in the treatment of severe premenstrual syndrome. Fertil. Steril., 2001; 76:850–852.

Di Paolo T., et al. Effect of acute and chronic 17-beta-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat. Exp. Brain. Res., 1983; 51:73–76.

Di Renzo G. C., et al. Progesterone and pregnancy. Curr. Opin. Obstet. Gynecol., 2005; 17: 589–600.

Di Renzo G. C., et al. The role of progesterone in maternal and fetal medicine. Gynecol. Endocrinol., 2012; 28 (11):925–932.

Di Zerega G. S., Hodgen G. D. Folliculogenesis in the primate ovarian cycle. Endocr. Rev., 1981; 2:27–49.